Clarius Group, LLC Compugen LTD Transaction History

Clarius Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	BUY	$2.8 - $4.14 $28,000 - $41,400	10,000 New	10,000 $38,000
Q4 2018 Feb 11, 2019	SELL	$2.17 - $3.8 $21,700 - $38,000	-10,000 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$2.75 - $3.95 $27,500 - $39,500	10,000	10,000 $38,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Clarius Group, LLC with notifications on news.